ALPHACENTRIC ADVISORS LLC – BioCryst Pharmaceuticals, Inc. Transaction History
ALPHACENTRIC ADVISORS LLC portfolio value:
$882,000
portfolio value
ALPHACENTRIC ADVISORS LLC quarter portfolio value change:
-8.63%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +300.00% | 52.5K shares | 640K | $12.6 | 70K |
| Q4 2021 | share | Increase | 0.00% | 17.5K shares | 242K | $13.79 | 17.5K |